Nabriva Therapeutics PLC (NBRVF)

[realfast95]

Friday 4/20 after the close 8K

As previously reported, on March 16, 2018, Nabriva Therapeutics plc (the “Company”) entered into a Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co., as agent (“Cantor Fitzgerald”), pursuant to which the Company may offer and sell ordinary shares (the “Ordinary Shares”), nominal value $0.01 per share, for aggregate gross sale proceeds of up to $50,000,000 from time to time through Cantor Fitzgerald under an “at-the-market” offering program (the “ATM Program”). On April 20, 2018, the Company made a filing with the Irish Companies Registration Office reporting that it had issued and sold an aggregate of 3,590,568 Ordinary Shares under the ATM Program between March 23, 2018 and April 17, 2018. As of April 20, 2018, the Company had 40,306,924 Ordinary Shares issued and outstanding.